8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride

8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride Suppliers list
Company Name: Nanjing Norris-Pharm Technology Co., Ltd  
Tel: 13901585132
Email: sales@norris-pharm.com
Company Name: Hangzhou Milestone Pharmtech Co., Ltd.  
Tel: 0571-82896630 18969958410
Email: sales_hz@milestonepharmtech.com
Company Name: NovoChemy Ltd.  
Tel: 86-(0)21-31261262 373522135
Email: sales@novochemy.com
Company Name: Shanghai Kahn Pharmaceutical Co., Ltd.  
Tel: 021-34979681; 17701870669
Email: 41513101@qq.com
Company Name: SuZhou ShiYa Biopharmaceuticals, Inc.  
Tel: 0512-0512-52358471 17715136450
Email: sales@shiyabiopharm.com
8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride Basic information
Product Name:8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride
Synonyms:8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine 1HCl salt;8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine;2H-1,4-Benzoxazine, 8-fluoro-3,4-dihydro-;8-Fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine;8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride
CAS:898832-40-1
MF:C8H8FNO
MW:153.15
EINECS:
Product Categories:
Mol File:898832-40-1.mol
8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride Structure
8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride Chemical Properties
Boiling point 238℃
density 1.200
Fp 98℃
storage temp. Sealed in dry,Room Temperature
AppearanceBrown to reddish brown Liquid
Safety Information
HS Code 2934999090
MSDS Information
8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride Usage And Synthesis
Synthesis
8-FLUORO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

560082-51-1

8-FLUORO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE HYDROCHLORIDE

898832-40-1

8-Fluoro-2H-1,4-benzoxazin-3(4H)-one (1.0 g, 5.9 mmol) was used as starting material, which was dissolved in THF (25 mL) and stirred to form a suspension at 0 °C to -5 °C. Subsequently, a THF solution of lithium aluminum hydride (7 mL, 1 M) was slowly added dropwise. After the dropwise addition, the reaction mixture was warmed to room temperature and stirring was continued for 2 hours. Upon completion of the reaction, the mixture was carefully poured into ice water to quench the reaction and extracted with ethyl acetate. The organic phases were combined, dried with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to remove the solvent. The resulting residue was ground with ether to afford 8-fluoro-3,4-dihydro-2H-benzo[1,4]oxazine (0.8 g, 87% yield) as a dark brown solid. Mass spectrum (ESI+): m/z 154 [M+H]+. 1H NMR (DMSO-d6): δ 3.27 (2H, m), 4.11 (2H, m), 6.05 (1H, br s), 6.34 (2H, m), 6.58 (1H, m).

References[1] Patent: WO2011/144578, 2011, A1. Location in patent: Page/Page column 30
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 16, p. 4700 - 4704
8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride Preparation Products And Raw materials
Raw materials8-Fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one-->Tetrahydrofuran-->Lithium Aluminum Hydride
Tag:8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride(898832-40-1) Related Product Information
6,8-Difluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride 6-Bromo-8-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one 8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine hydrochloride 8-Fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one Oxygen-fluorine acid Levofloxacin carboxylic acid Ethyl (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate AKOS 1305 BUTTPARK 120\07-80 9,10-Difluoro-2,3-dihydro-2-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid